Stockscreener 앱 받기
91.15
1.32%
-1.22
Guardant Health Inc 주식(GH)의 최신 뉴스
Guardant Health Stock Rises on Japan Regulatory News for Daiichi Sankyo DrugNews and Statistics - IndexBox
Director at Guardant Health (GH) acquires 155 shares via RSUs - Stock Titan
Quarterly Recap: Can Guardant Health Inc maintain its current growth rate2026 Institutional Moves & Smart Allocation Stock Reports - baoquankhu1.vn
Guardant Health (GH) Gains Momentum on Promising Outlook - GuruFocus
Guardant Health gets oncology innovation accolade at Healthcare Asia Medtech Awards 2026 - Mugglehead Magazine
Why Is Guardant Health (GH) Stock Soaring Today - Yahoo Finance
Guardant Health (GH) partners with Manulife to launch Shield multi-cancer detection test in Asia - MSN
Guardant Health (GH) and Verana Health Announces New Partnership - Insider Monkey
INVESCO Small Cap Equity Fund's Guardant Health Inc(GH) Holding History - GuruFocus
Guardant Health real-world data supports Japan approval of ENHERTU for HER2-positive tumors - MSN
The Bull Case For Guardant Health (GH) Could Change Following Japan’s ENHERTU Approval Using Its AI Data - simplywall.st
Guardant Health (GH) Supports Approval of Cancer Treatment in Ja - GuruFocus
Guardant Health Inc (GH) Trading Down 3.96% on Mar 30 - GuruFocus
Guardant Health's AI Data Supports ENHERTU Approval - National Today
Guardant Health's Infinityai real-world evidence supports approval of Enhertu® for previously treated patients with HER2-positive metastatic solid tumors in Japan - MarketScreener
Guardant Health’s InfinityAI Real-World Evidence Supports Approval of ENHERTU® for Previously Treated Patients with HER2-Positive Metastatic Solid Tumors in Japan - Business Wire
Liquid Biopsy Market Is Booming Rapidly with Strong Demand By 2033 | Guardant Health Inc., Foundation Medicine Inc. - openPR.com
Oncology Biomarkers Market Trends and Investment Opportunities Report 2026-2030: Global, Regional and Country-Level Outlook - GlobeNewswire Inc.
(GH) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
5 High Growth Healthcare Stocks to Buy Now - Insider Monkey
GH PE Ratio & Valuation, Is GH Overvalued - intellectia.ai
Guardant Health to present new cancer research while stock trades lower amid strong sell signals - Traders Union
Guardant Health Shares Fall as Market Reacts to Conflict, Policy Deadlines | 2026News and Statistics - IndexBox
Why Guardant Health (GH) Stock Is Falling Today - Yahoo Finance
Vanguard disaggregates holdings; reports 0% of Guardant Health (GH) - Stock Titan
GH Stock Price, Quote & Chart | GUARDANT HEALTH INC (NASDAQ:GH) - ChartMill
Guardant Health wins at Healthcare Asia Medtech Awards 2026 - healthcareasiamagazine.com
Tempus AI Reinforces Market Position With Collaborations in 2026 - TradingView
Guardant Health Ignites 5.6% Surge: A Volatile Breakout or a Trap for the Unwary? - Bitget
Verana Health and Guardant Health Partner to Advance Precision Medicine with Real-World Data - Lelezard
Verana and Guardant’s RWE Stack Aims to Solve Precision Oncology’s Data Challenges—Driving Growth Through Recurring Revenue and Broader Data Collections - Bitget
Guardant Health Manulife Shield Partnership Highlights Asia Growth And Valuation Gap - Yahoo Finance
Guardant Health (GH) director’s RSU vesting adds 264 common shares - Stock Titan
How Guardant’s Shield Blood Test Rollout Through Quest Diagnostics (DGX) Has Changed Its Investment Story - Yahoo Finance
GH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Multiple analysts lift Guardant Health, Inc. (GH) targets on screening and data growth - MSN
Insiders Shake Up Guardant, Ovintiv, Redwire, Builders FirstSource, Permian - TipRanks
Why Guardant Health’s (GH) 2026 screening story reinforced Piper Sandler’s bullish view - MSN
Guardant Health (GH) Partners With Manulife to Launch Shield Multi-Cancer Detection Test in Asia - Insider Monkey
Guardant Health to present 28 abstracts on multiomic cancer research at AACR26 - Traders Union
Guardant Health, Inc. $GH Shares Sold by Polar Asset Management Partners Inc. - MarketBeat
Insider Sell: Musa Tariq Sells Shares of Guardant Health Inc (GH) - GuruFocus
Guardant Health (GH) director Tariq Musa sells $30,655 in stock By Investing.com - Investing.com Australia
Insider Selling: Guardant Health (NASDAQ:GH) Director Sells 348 Shares of Stock - MarketBeat
Guardant Health (GH) director Tariq Musa sells $30,655 in stock - Investing.com
Guardant Health (NASDAQ: GH) director sells 348 company shares - Stock Titan
3 Reasons to Steer Clear of GH and One Alternative Stock Worth Buying - Bitget
Guardant Health Stock Analysis: Price Rise vs. Financial Risks | 2026News and Statistics - IndexBox
3 Reasons to Avoid GH and 1 Stock to Buy Instead - Yahoo Finance
0.87%
자본화:
|
볼륨(24시간):